CN110326776A - 一种适合航天员的提高免疫力的药食同源复合制剂 - Google Patents
一种适合航天员的提高免疫力的药食同源复合制剂 Download PDFInfo
- Publication number
- CN110326776A CN110326776A CN201910006290.3A CN201910006290A CN110326776A CN 110326776 A CN110326776 A CN 110326776A CN 201910006290 A CN201910006290 A CN 201910006290A CN 110326776 A CN110326776 A CN 110326776A
- Authority
- CN
- China
- Prior art keywords
- parts
- drinking
- integration
- medicinal herbs
- immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims abstract description 9
- 230000035622 drinking Effects 0.000 title claims abstract description 9
- 235000008216 herbs Nutrition 0.000 title claims abstract description 9
- 230000010354 integration Effects 0.000 title claims abstract description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 17
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 17
- 229940082787 spirulina Drugs 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 241000229143 Hippophae Species 0.000 claims abstract description 9
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 9
- 241000218231 Moraceae Species 0.000 claims abstract description 9
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 239000007935 oral tablet Substances 0.000 abstract description 2
- 229940096978 oral tablet Drugs 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 7
- 240000000249 Morus alba Species 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 3
- 229960002733 gamolenic acid Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- -1 antibiotic Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000037451 immune surveillance Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种制剂，涉及一种适合航天员的提高免疫力的药食同源复合制剂。由螺旋藻粉、桑葚、茯苓、黄精、枸杞、沙棘果、低聚果糖混合制备而成。本发明易生产，成本低，口感好，易吸收，可增强机体抵抗病原体感染的能力，提高身体的健康水平，是一种良好的增强免疫力的口服片剂。
Description
技术领域
本发明涉及一种制剂，涉及一种适合航天员的提高免疫力的药食同源复合制剂。
背景技术
免疫是一种机体抵抗病原体感染的能力。人体免疫系统具有三种保护功能 ：①防御功能 ：抵抗细菌、病毒、真菌等的致病微生物侵袭 ；②稳定功能 ：及时清除体内衰老的死亡细胞，以免妨碍机体正常功能的发挥，从而保持体内的稳定 ；③免疫监视功能 ：及时发现和消灭体内发生变异的细胞，防止癌症的发生。人之所以能在各种环境中健康地生存，人体免疫系统起着决定性的作用，当身体受不良环境、饮食、情绪等诸多因素的影响，会引起个别细胞发生突变。正常情况下，在免疫系统的作用下，突变的细胞会被消灭。但对于免疫力低下的人，其免疫活性细胞不能识别突变细胞，使其生长繁殖，最后发展成为癌症。因此，增强免疫力，提高人体对病原的抵抗能力已成为日益重视的一个问题。
月球表面的低重力环境和太空飞行中的高重力环境，将会对人体的心血管系统、免疫系统、神经系统、骨骼肌肉等系统造成危害性影响。二是宇宙辐射带来的挑战。在月球上由于缺乏月球地磁场的屏蔽作用，宇航员在月球表面外面活动时间过长的时候，极易受到这种辐射的伤害。因此有必要研发一种适合航天员的提高免疫力的药食同源复合制剂。
发明内容
本发明的目的是针对航天员飞行期间免疫系统遭到影响，利用螺旋藻粉、桑葚、茯苓、黄精、枸杞、沙棘果、低聚果糖增强人体的免疫力功能，增强机体抵抗病原体感染的能力。
本发明所采用的技术方案 ：
一种增强免疫力的食品，由螺旋藻粉、桑葚、茯苓、黄精、枸杞、沙棘果、低聚果糖混合制备而成。其中按质量份数计，具体由如下组份制得 ：螺旋藻50-60份、桑葚10-15份、茯苓8-12份、黄精10-15份、枸杞8-20份、沙棘果1-6份、低聚果糖1-5份。
本发明涉及的适合航天员的提高免疫力的药食同源复合制剂为口服片剂。
本发明的制作方法是 ：按上述配方将各组份称重，混匀，然后采用传统工艺制备成所需的剂型，包装即成。
一种适合航天员的提高免疫力的药食同源复合制剂，主要功能成分螺旋藻粉的作用是：
螺旋藻粉是一种绿色又健康的保健食品，对改善人体的肠胃功能以及增加免疫力有着特殊作用，同时还有养颜护肤的功效。
1、改善肠胃功能
有效改善胃病症状，对抗各种腹泻和便秘。
2、维持血液酸碱平衡
超碱性食品，丰富的碱性矿物质（尤其是钾与钙质），可维持血液中酸碱值的平衡，降低胆固醇，减轻高血压和心脏病症状或减少其发病几率。
3、防治贫血
防治贫血，类胡萝卜素含量是胡萝卜的1.5倍，维生素B12含量是猪肝的4倍，铁含量是菠菜的23倍。
4、预防心脑血管疾病
含有人体自身不能合成的亚麻酸，帮助脂肪代谢，防止血栓形成，有效对抗心脑血管疾病，预防脂肪肝和肝硬化，降低血糖，预防糖尿病。
5、减低药物对身体损坏程度
预防因服用镇定剂、抗生素、抗癌剂等对肾机能的损害。减轻汞及药物对肾的毒性，使人体免受重金属的毒害。
6、美容功效
减肥，美容，去暗疮、黄褐斑，抗衰老。
螺旋藻的营养价值
螺旋藻中的蛋白质含量相当于大豆的1.5倍，大米的10倍，猪肉的4倍，牛肉的3倍，鸡肉的3.7倍，鸡蛋的5倍，鱼肉的3倍，干酪的2.4倍；螺旋藻中的β-胡萝卜素含量是胡萝卜的15倍，螺旋藻中的维生素B12含量是猪肝的4倍；每100克藻粉中，γ-亚麻酸含量高达1200毫克以上。到目前为止，被人们公认可以直接食用的γ-亚麻酸只有人乳和螺旋藻中才含有，螺旋藻的γ-亚麻酸含量是人乳的500倍；螺旋藻中叶绿素含量极为丰富，是大多陆生植物2-3倍，是普通蔬菜含量的10倍以上，螺旋藻中脂肪含量只有5%，猪肉含量为50%，牛肉含量为24.08%，鱼肉含量为4%，鸡蛋为8.8%；螺旋藻中多糖高达14%-16%/g，灵芝含量为1.28%/g倍，芦荟含量为1%/kg。
主要功能成分桑葚的作用是：
桑葚有改善皮肤(包括头皮)血液供应，营养肌肤，使皮肤白嫩及乌发等作用，并能延缓衰老。桑椹是中老年人健体美颜、抗衰老的佳果与良药。常食桑椹可以明目，缓解眼睛疲劳干涩的症状。桑椹具有免疫促进作用。桑椹对脾脏有增重作用，对溶血性反应有增强作用，可防止人体动脉硬化、骨骼关节硬化，促进新陈代谢。它可以促进血红细胞的生长，防止白细胞减少，并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助功效。桑椹具有生津止渴、促进消化、帮助排便等作用，适量食用能促进胃液分泌，刺激肠蠕动及解除燥热。祖国医学认为，桑椹性味甘寒，具有补肝益肾、生津润肠、乌发明目等功效。
主要功能成分茯苓的作用是：
1、利尿作用
2、抗菌作用
3、对消化系统的影响
4、降低血糖
5、对心脏的作用
6、抗肿瘤作用
7、对免疫功能的影响
（1）增加巨噬细胞的细胞毒性作用；
（2）羟甲基茯苓多糖能明显增强小鼠脾抗体分泌细胞数以及特异的抗原结合细胞数；
（3）增加酸性非特异酯酶阳性淋巴细胞数；
（4）增强T淋巴细胞的细胞毒性；
8、对血液系统的影响
9、对中枢神经系统的影响
10、抗癌
11、补气健脾
12、治痰。
主要功能成分枸杞的作用是：
其味甘、性平具有补肝益肾之功效，《本草纲目》中说“久服坚筋骨，轻身不老，耐寒暑。”中医常用它来治疗肝肾阴亏、腰膝酸软、头晕、健忘、目眩、目昏多泪、消渴、遗精等病症。现代药理学研究证实枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用，并应用于临床。枸杞子服用方便，可入药、嚼服、泡酒。但外邪实热，脾虚有湿及泄泻者忌服。
主要功能成分沙棘果的作用是：
沙棘果，性温，味酸。含有的大量氨基酸和有机酸等，能够促进胃液分泌，可以起到养胃健脾，理气疏肝及助消化的功效；含有的黄酮类物质，可以消炎及促进毛细血管血液循环，起到平喘止咳，利肺化痰的功效；含有的有机酸，可以起到排除肝脏毒素的作用，可以保护肝脏；含有的磷脂类化合物，可以促进细胞代谢，起到改善肝功能，预防脂肪肝及肝硬化的功效；沙棘还可以降低胆固醇，起到预防冠状动脉粥样硬化性心脏病发生的功效。
具体实施方式
按质量份数计，具体由如下组份制得 ：
螺旋藻50-60份
桑葚10-15份
茯苓8-12份
黄精10-15份
枸杞8-20份
沙棘果1-6份
低聚果糖1-5份。
按照重量配比加入物料、混合、制颗粒、干燥、整拉、压片、检验、包装、成品，即制成具有辅助提高人体免疫力的片剂产品。
袁某，男，50 岁。经常头昏头痛、疲乏无力、精神不佳、脸无血色，食欲不振，春冬季几乎每月都要感冒。服用本品 30 天后，上述症状明显好转。继续服用后，自感精神好，无明显疲劳感，面色红润，工作精力充沛，整个冬天未发生感冒、气管炎等。
Claims (3)
1.本发明公开了一种适合航天员的提高免疫力的药食同源复合制剂，其特征在于：是以螺旋藻，桑葚、茯苓、黄精、枸杞、沙棘果、低聚果糖为组分制得的片剂。
2.根据权利要求1的一种适合航天员的提高免疫力的药食同源复合制剂，其特征在于：具体由如下组份制得：螺旋藻50-60份、桑葚10-15份、茯苓8-12份、黄精10-15份、枸杞8-20份、沙棘果1-6份、低聚果糖1-5份。
3.经过实验，证实本发明制剂能够提高免疫力。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910006290.3A CN110326776A (zh) | 2019-01-04 | 2019-01-04 | 一种适合航天员的提高免疫力的药食同源复合制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910006290.3A CN110326776A (zh) | 2019-01-04 | 2019-01-04 | 一种适合航天员的提高免疫力的药食同源复合制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110326776A true CN110326776A (zh) | 2019-10-15 |
Family
ID=68138893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910006290.3A Withdrawn CN110326776A (zh) | 2019-01-04 | 2019-01-04 | 一种适合航天员的提高免疫力的药食同源复合制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110326776A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112273649A (zh) * | 2020-11-03 | 2021-01-29 | 深圳市新靶向生物科技有限公司 | 一种抗氧化、抗衰老的组合物及制备方法和应用 |
| CN113208112A (zh) * | 2021-06-07 | 2021-08-06 | 中科浩淋生物技术有限公司 | 一种滋胰养肝控糖细胞营养素 |
-
2019
- 2019-01-04 CN CN201910006290.3A patent/CN110326776A/zh not_active Withdrawn
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112273649A (zh) * | 2020-11-03 | 2021-01-29 | 深圳市新靶向生物科技有限公司 | 一种抗氧化、抗衰老的组合物及制备方法和应用 |
| CN112273649B (zh) * | 2020-11-03 | 2022-06-21 | 深圳市新靶向生物科技有限公司 | 一种抗氧化、抗衰老的组合物及制备方法和应用 |
| CN113208112A (zh) * | 2021-06-07 | 2021-08-06 | 中科浩淋生物技术有限公司 | 一种滋胰养肝控糖细胞营养素 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103141712B (zh) | 一种蛋鸡产蛋期配合饲料及其制备方法 | |
| CN108523122A (zh) | 一种减肥代餐粉 | |
| CN102138671A (zh) | 一种人参八珍保健糕的配方和制成方法 | |
| CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
| CN106858595A (zh) | 一种烧伤专用型临床营养配方及其制备方法 | |
| KR20020022342A (ko) | 스트레스 예방 및 치료를 위한 항스트레스제 조성물 | |
| CN108477609A (zh) | 一种牛蒡减肥代餐棒及其制备方法 | |
| CN107373672A (zh) | 一种月经不调女性专用型临床营养配方及其制备方法 | |
| CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
| CN104824674A (zh) | 一种防治脱发的营养保健食品 | |
| CN110326776A (zh) | 一种适合航天员的提高免疫力的药食同源复合制剂 | |
| CN109349421A (zh) | 一种肉鸽促生长生态饲料及其制备方法 | |
| CN109497458A (zh) | 一种大鲵营养均衡养生食品及其制备方法 | |
| CN105533233A (zh) | 一种防治家禽寄生虫病的中药饲料配方 | |
| CN103920140B (zh) | 一种人用降糖减肥降脂复方制剂 | |
| CN108066384A (zh) | 一种具有增强免疫力功能的中药制剂及其制备方法 | |
| RU2458538C1 (ru) | Продукт диетического, профилактического и функционального питания для спортивного питания с пробиотиком в | |
| CN103005467B (zh) | 一种保肝营养组合物及其保肝营养食品 | |
| CN108576801A (zh) | 一种减肥保健食品及其制备方法 | |
| CN108464406A (zh) | 促进肉鸡生长、改善肉质风味的肉鸡饲料及其制备方法 | |
| WO2018113376A1 (zh) | 一种肝郁型肥胖的减肥食品及其用途及其制备工艺 | |
| JP2007131605A (ja) | 不定愁訴改善組成物及び食品 | |
| CN113841884A (zh) | 改善营养代谢的速溶代餐粉配方及其制作方法 | |
| CN111972656A (zh) | 一种香菇酱及其制备方法 | |
| CN106072165A (zh) | 人参阿胶魔芋粉 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20191015 |
|
| WW01 | Invention patent application withdrawn after publication |